Literature DB >> 17854272

Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549.

Qi Yu1, Benli Su, Dandan Liu, Ben Liu, Ying Fan, Yingyan Wang, Xiuxiang Meng.   

Abstract

The oncogene Bmi-1 regulates cell proliferation and senescence. It is reported that it controlled the self-renewal of leukemic and breast cancer stem cell and was overexpressed in some solid tumors and hematologic malignancies. In this study, the effects of inactivation of Bmi-1 mediated by a plasmid-expressing antisense Bmi-1 RNA on the proliferation of lung cancer cell line A549 were investigated. As a result, when the plasmid was stably introduced into the cell line, the Bmi-1 protein level was specifically downregulated, and the cell proliferation was significantly inhibited as shown by the cell growth curve and colony forming assay. The cells were found mostly in the phase of G(0)/G(1) and cells in S phase were significantly decreased. Our results suggest that targeting Bmi-1 might be a therapeutic potential for the treatment of non-small-cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854272     DOI: 10.1089/oli.2007.0070

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  12 in total

1.  Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis.

Authors:  Yongsheng Zhang; Lu Han; Jian Pang; Yang Wang; Fan Feng; Qiyu Jiang
Journal:  Tumour Biol       Date:  2015-12-30

Review 2.  Polycomb group proteins are key regulators of keratinocyte function.

Authors:  Richard L Eckert; Gautam Adhikary; Ellen A Rorke; Yap Ching Chew; Sivaprakasam Balasubramanian
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

3.  Bmi-1-shRNA inhibits the proliferation of lung adenocarcinoma cells by blocking the G1/S phase through decreasing cyclin D1 and increasing p21/p27 levels.

Authors:  Xiangyu Zheng; Yifang Wang; Ben Liu; Chunqing Liu; Dandan Liu; Jie Zhu; Chunhui Yang; Jiangzhou Yan; Xiaobo Liao; Xiuxiang Meng; Hong Yang
Journal:  Nucleic Acid Ther       Date:  2014-02-19       Impact factor: 5.486

4.  The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Gautam Adhikary; Richard L Eckert
Journal:  Carcinogenesis       Date:  2009-12-16       Impact factor: 4.944

5.  Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.

Authors:  Chuan-Rui Xu; Susie Lee; Coral Ho; Prashant Bommi; Shi-Ang Huang; Siu Tim Cheung; Goberdhan P Dimri; Xin Chen
Journal:  Mol Cancer Res       Date:  2009-11-24       Impact factor: 5.852

6.  Prognostic and predictive markers in medullary thyroid carcinoma.

Authors:  Boban M Erovic; Dae Kim; Clarissa Cassol; David P Goldstein; Jonathan C Irish; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

Review 7.  Stem cells and solid cancers.

Authors:  Stuart A C McDonald; Trevor A Graham; Stefanie Schier; Nicholas A Wright; Malcolm R Alison
Journal:  Virchows Arch       Date:  2009-06-05       Impact factor: 4.064

8.  Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study.

Authors:  Katerina Vrzalikova; Joseph Skarda; Jiri Ehrmann; Paul G Murray; Eduard Fridman; Jury Kopolovic; Petra Knizetova; Marian Hajduch; Jiri Klein; Vitezslav Kolek; Lenka Radova; Zdenek Kolar
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

9.  RNAi-mediated silencing of the Bmi-1 gene causes growth inhibition and enhances doxorubicin-induced apoptosis in MCF-7 cells.

Authors:  Xiang-Mei Wu; Xing Liu; You-Quan Bu; Joyeeta Sengupta; Hong-Juan Cui; Fa-Ping Yi; Tao Liu; Chen-Fu Yuan; Yan-Yan Shi; Fang-Zhou Song
Journal:  Genet Mol Biol       Date:  2009-12-01       Impact factor: 1.771

10.  Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer.

Authors:  Matthias Becker; Christian Korn; Arnold R Sienerth; Robert Voswinckel; Katharina Luetkenhaus; Fatih Ceteci; Ulf R Rapp
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.